Pnc Financial Services Group, Inc. Lava Therapeutics Nv Transaction History
Pnc Financial Services Group, Inc.
- $153 Billion
- Q2 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 65,000 shares of LVTX stock, worth $99,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,000
Previous 65,000
-0.0%
Holding current value
$99,450
Previous $82,000
3.66%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.94MCall Options Held
17.9KPut Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$3.17 Million0.33% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.97MShares$3.02 Million1.97% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$798,4670.29% of portfolio
-
Pathway Financial Advisors LLC103KShares$156,8250.02% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il51.8KShares$79,2600.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $39.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...